Mezzion Pharma Co.Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.122x

Mezzion Pharma Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Mezzion Pharma Co.Ltd (140410) has a cash flow conversion efficiency ratio of -0.122x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.75 Billion ≈ $-3.22 Million USD) by net assets (₩39.04 Billion ≈ $26.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Mezzion Pharma Co.Ltd (2012–2025)

Cash flow conversion efficiency of Mezzion Pharma Co.Ltd from 2012 to 2025. This chart illustrates how Mezzion Pharma Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 140410 share price today for real-time trading data and today's change.

Mezzion Pharma Co.Ltd Cash Flow Conversion Ratio Explained

Mezzion Pharma Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mezzion Pharma Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mezzion Pharma Co.Ltd ranked by their cash flow conversion efficiency. Also see 140410 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Izertis Sa MC:IZER	0.261x
Chongqing New Dazheng Property Grp SHE:002968	0.029x
Community Health Systems Inc NYSE:CYH	-0.076x
Shenzhen Tongyi Industry Co Ltd SHE:300538	-0.017x
Ring Energy Inc NYSE MKT:REI	0.042x
Panin Financial Tbk JK:PNLF	0.014x
Clearview Wealth Ltd AU:CVW	-3.782x
Nanjing Chixia Development Co Ltd SHG:600533	0.003x

Annual Cash Flow Conversion Efficiency for Mezzion Pharma Co.Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Mezzion Pharma Co.Ltd from 2012 to 2025. Review Mezzion Pharma Co.Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩17.19 Billion ≈ $11.65 Million	₩-16.59 Billion ≈ $-11.24 Million	-0.965x	-140.34%
2024-12-31	₩46.06 Billion ≈ $31.22 Million	₩-18.49 Billion ≈ $-12.53 Million	-0.401x	-123.74%
2023-12-31	₩61.44 Billion ≈ $41.64 Million	₩-11.02 Billion ≈ $-7.47 Million	-0.179x	+61.01%
2022-12-31	₩26.24 Billion ≈ $17.78 Million	₩-12.07 Billion ≈ $-8.18 Million	-0.460x	-91.72%
2021-12-31	₩62.79 Billion ≈ $42.55 Million	₩-15.07 Billion ≈ $-10.21 Million	-0.240x	-84.84%
2020-12-31	₩56.81 Billion ≈ $38.50 Million	₩-7.38 Billion ≈ $-5.00 Million	-0.130x	+73.36%
2019-12-31	₩42.83 Billion ≈ $29.03 Million	₩-20.88 Billion ≈ $-14.15 Million	-0.488x	-28.63%
2018-12-31	₩57.32 Billion ≈ $38.84 Million	₩-21.72 Billion ≈ $-14.72 Million	-0.379x	-52.50%
2017-12-31	₩53.17 Billion ≈ $36.03 Million	₩-13.21 Billion ≈ $-8.95 Million	-0.249x	-115.96%
2016-12-31	₩52.81 Billion ≈ $35.79 Million	₩-6.08 Billion ≈ $-4.12 Million	-0.115x	-506.08%
2015-12-31	₩62.54 Billion ≈ $42.38 Million	₩1.77 Billion ≈ $1.20 Million	0.028x	-42.77%
2012-12-31	₩63.34 Billion ≈ $42.92 Million	₩3.14 Billion ≈ $2.13 Million	0.050x	--

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$289.01 Million

₩426.46 Billion KRW

Market Cap Rank

#14696 Global

#468 in Korea

Share Price

₩49900.00

Change (1 day)

-2.92%

52-Week Range

₩49900.00 - ₩172700.00

All Time High

₩172700.00